Prospective, open, multicentre clinical trial (phase II) of Endostar(recombinant human endostatin) on combined radiotherapy and chemotherapy for esophageal cancer.

Trial Profile

Prospective, open, multicentre clinical trial (phase II) of Endostar(recombinant human endostatin) on combined radiotherapy and chemotherapy for esophageal cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Cisplatin; Endostatin; Paclitaxel
  • Indications Oesophageal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Jan 2012 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
    • 15 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top